Publications by authors named "D Farges"

Claim this Profile
T
The first year of treatment with selumetinib for NF1-related plexiform neurofibroma is medically challenging in real-life settings.
P Boitez, D Farges, M Descamps, V Bournazel, L Martin

Ann Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin.
N Sigg, J Fouquet, D Morin, D Farges, S Vrignaud

Ann Dermatol Venereol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of mTOR inhibitors (rapalogs) for the treatment of skin changes in tuberous sclerosis complex.
D Farges, N Sigg, D Ville, L Martin

Arch Pediatr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive functions in preschool-aged children with neurofibromatosis type 1: Value for early assessment.
Marie-Laure Beaussart-Corbat, Sébastien Barbarot, Denis Farges, Ludovic Martin, Arnaud Roy

J Clin Exp Neuropsychol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevalence of the tuberous sclerosis complex at patients taken care for a renal angiomyolipoma].
P Maulaz, M C Malinge, D Farges, O Ingster, A R Azzouzi

Prog Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis